The new Wegovy subscription program offers up to $1,200 in annual savings with predictable, tiered monthly pricing designed ...

Wegovy, a popular weight loss drug, may soon be more affordable for some people through a new subscription program.

Novo Nordisk (NVO) launches Wegovy subscription plans with discounts up to 29% for U.S. self-pay patients as it battles Eli Lilly for GLP-1 market dominance.

Novo Nordisk A/S NVO on Tuesday introduced a multi-month subscription program for its obesity treatment Wegovy (semaglutide), aiming to make pricing more predictable for self-pay patients and improve ...

The new multi-month subscription program launched March 31, 2026 offers eligible self-pay patients a fixed monthly price for ...

Novo Nordisk rolled out a multi-month subscription plan for Wegovy, the “first and only” program of its kind that the ...

Shares of Novo Nordisk NVO rose 4.1% on Tuesday following its announcement of a new multi-month subscription program for its ...